IS6784A - Blanda til inntöku um munn sem felur í sér efnasamband sem hamlar flutningi galls í dausgörn og HMGCo-A redúktasahemil - Google Patents
Blanda til inntöku um munn sem felur í sér efnasamband sem hamlar flutningi galls í dausgörn og HMGCo-A redúktasahemilInfo
- Publication number
- IS6784A IS6784A IS6784A IS6784A IS6784A IS 6784 A IS6784 A IS 6784A IS 6784 A IS6784 A IS 6784A IS 6784 A IS6784 A IS 6784A IS 6784 A IS6784 A IS 6784A
- Authority
- IS
- Iceland
- Prior art keywords
- oral
- hmgco
- inhibits
- compound
- composition containing
- Prior art date
Links
- 229940123934 Reductase inhibitor Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000029142 excretion Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0003766A SE0003766D0 (sv) | 2000-10-18 | 2000-10-18 | Novel formulation |
| PCT/GB2001/004525 WO2002032428A1 (en) | 2000-10-18 | 2001-10-12 | Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS6784A true IS6784A (is) | 2003-04-14 |
Family
ID=20281462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS6784A IS6784A (is) | 2000-10-18 | 2003-04-14 | Blanda til inntöku um munn sem felur í sér efnasamband sem hamlar flutningi galls í dausgörn og HMGCo-A redúktasahemil |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20050101611A1 (is) |
| EP (1) | EP1351692A1 (is) |
| JP (1) | JP2004511521A (is) |
| KR (1) | KR20020062970A (is) |
| CN (1) | CN1400902A (is) |
| AU (1) | AU2001294002A1 (is) |
| BR (1) | BR0107333A (is) |
| CA (1) | CA2425831A1 (is) |
| HU (1) | HUP0301087A3 (is) |
| IL (1) | IL150104A0 (is) |
| IS (1) | IS6784A (is) |
| MX (1) | MXPA03003417A (is) |
| NO (1) | NO20022894L (is) |
| NZ (1) | NZ525371A (is) |
| PL (1) | PL360937A1 (is) |
| SE (1) | SE0003766D0 (is) |
| SK (1) | SK4732003A3 (is) |
| WO (1) | WO2002032428A1 (is) |
| ZA (1) | ZA200204771B (is) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0000772D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | Chemical compounds |
| EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
| GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
| GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| MY131995A (en) | 2001-09-08 | 2007-09-28 | Astrazeneca Ab | Benzothiazepine and benzothiadiazepine derivatives with illeal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
| CA2489834C (en) | 2002-06-20 | 2006-10-03 | Astrazeneca Ab | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| GB0216321D0 (en) * | 2002-07-13 | 2002-08-21 | Astrazeneca Ab | Therapeutic treatment |
| GB0304194D0 (en) | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
| GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
| MX366925B (es) | 2010-11-04 | 2019-07-31 | Albireo Ab | Inhibidores de ibat para el tratamiento de enfermedades hepaticas. |
| US20130236541A1 (en) | 2010-11-08 | 2013-09-12 | Albireo Ab | Pharmaceutical combination comprising an ibat inhibitor and a bile acid binder |
| JP6217938B2 (ja) | 2011-10-28 | 2017-10-25 | ルメナ ファーマシューティカルズ エルエルシー | 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤 |
| EA038594B1 (ru) | 2011-10-28 | 2021-09-21 | Шайр Хьюман Дженетик Терапис, Инк. | Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени |
| JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
| CA2952406A1 (en) | 2014-06-25 | 2015-12-30 | Ea Pharma Co., Ltd. | Solid formulation and method for preventing or reducing coloration thereof |
| EP3012252A1 (en) | 2014-10-24 | 2016-04-27 | Ferring BV | Crystal modifications of elobixibat |
| CN105362244A (zh) * | 2015-11-26 | 2016-03-02 | 青岛海之源智能技术有限公司 | 考来烯胺缓释片及制备方法 |
| CN108601744B (zh) | 2016-02-09 | 2022-01-04 | 阿尔比里奥公司 | 口服考来烯胺制剂及其用途 |
| JP6954927B2 (ja) | 2016-02-09 | 2021-10-27 | アルビレオ・アクチボラグ | 経口コレスチラミン製剤及びその使用 |
| CA3011595C (en) | 2016-02-09 | 2024-01-02 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| CN111032019B (zh) | 2017-08-09 | 2022-07-05 | 阿尔比里奥公司 | 考来烯胺颗粒、口服考来烯胺制剂及其用途 |
| JP7328207B2 (ja) | 2017-08-09 | 2023-08-16 | アルビレオ・アクチボラグ | コレスチラミンペレット、経口コレスチラミン製剤、及びそれらの使用 |
| JP7391048B2 (ja) | 2018-06-05 | 2023-12-04 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| KR20210024033A (ko) | 2018-06-20 | 2021-03-04 | 알비레오 에이비 | 오데빅시바트의 약학 제제 |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| SG11202108566VA (en) | 2019-02-06 | 2021-09-29 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| CN113453753B (zh) | 2019-02-06 | 2024-07-23 | 阿尔比里奥公司 | 苯并硫氮杂环庚三烯化合物及其用作胆汁酸调节剂的用途 |
| WO2021110885A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| JP7665621B2 (ja) | 2019-12-04 | 2025-04-21 | アルビレオ・アクチボラグ | ベンゾチアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| CA3158181A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| CN114786772B (zh) | 2019-12-04 | 2024-04-09 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| CA3158195A1 (en) | 2019-12-04 | 2021-06-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
| ES3002777T3 (en) | 2020-08-03 | 2025-03-07 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| AU2021379076A1 (en) | 2020-11-12 | 2023-06-08 | Albireo Ab | Odevixibat for treating progressive familial intrahepatic cholestasis (pfic) |
| BR112023010799A2 (pt) | 2020-12-04 | 2023-10-03 | Albireo Ab | Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares |
| CN117412955A (zh) | 2021-06-03 | 2024-01-16 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| EP4536232A1 (en) | 2022-06-09 | 2025-04-16 | Albireo AB | Treating hepatitis |
| WO2025146507A1 (en) | 2024-01-05 | 2025-07-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| WO2025146508A1 (en) | 2024-01-05 | 2025-07-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4600578A (en) * | 1984-05-11 | 1986-07-15 | Bristol-Myers Company | Method of inhibiting diarrhea |
| US5362732A (en) * | 1989-12-20 | 1994-11-08 | University Of North Carolina At Chapel Hill | Boronated compounds |
| JPH04193836A (ja) * | 1990-11-26 | 1992-07-13 | Banyu Pharmaceut Co Ltd | 抗高脂血症剤 |
| FI108451B (fi) * | 1991-12-20 | 2002-01-31 | Hoechst Ag | Menetelmõ polymeeristen ja oligomeeristen sappihappojohdannaisten valmistamiseksi |
| IL108633A (en) * | 1993-02-15 | 1998-07-15 | Wellcome Found | History of Benzothiazepine Hypolipidemic Preparation and Pharmaceutical Preparations Containing Them |
| JPH07223970A (ja) * | 1994-02-10 | 1995-08-22 | Tanabe Seiyaku Co Ltd | 消化管内適所放出製剤 |
| GB9704208D0 (en) * | 1997-02-28 | 1997-04-16 | Glaxo Group Ltd | Chemical compounds |
| NZ337830A (en) * | 1997-03-11 | 2001-07-27 | G | Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
| GB9800428D0 (en) * | 1998-01-10 | 1998-03-04 | Glaxo Group Ltd | Chemical compounds |
-
2000
- 2000-10-18 SE SE0003766A patent/SE0003766D0/xx unknown
-
2001
- 2001-10-12 WO PCT/GB2001/004525 patent/WO2002032428A1/en not_active Ceased
- 2001-10-12 US US10/399,336 patent/US20050101611A1/en not_active Abandoned
- 2001-10-12 KR KR1020027007742A patent/KR20020062970A/ko not_active Ceased
- 2001-10-12 NZ NZ525371A patent/NZ525371A/en unknown
- 2001-10-12 MX MXPA03003417A patent/MXPA03003417A/es unknown
- 2001-10-12 PL PL36093701A patent/PL360937A1/xx not_active Application Discontinuation
- 2001-10-12 HU HU0301087A patent/HUP0301087A3/hu unknown
- 2001-10-12 JP JP2002535666A patent/JP2004511521A/ja not_active Withdrawn
- 2001-10-12 EP EP01974487A patent/EP1351692A1/en not_active Withdrawn
- 2001-10-12 SK SK473-2003A patent/SK4732003A3/sk unknown
- 2001-10-12 CA CA002425831A patent/CA2425831A1/en not_active Abandoned
- 2001-10-12 BR BR0107333-8A patent/BR0107333A/pt not_active IP Right Cessation
- 2001-10-12 IL IL15010401A patent/IL150104A0/xx unknown
- 2001-10-12 AU AU2001294002A patent/AU2001294002A1/en not_active Abandoned
- 2001-10-12 CN CN01804901A patent/CN1400902A/zh active Pending
-
2002
- 2002-06-13 ZA ZA200204771A patent/ZA200204771B/en unknown
- 2002-06-17 NO NO20022894A patent/NO20022894L/no unknown
-
2003
- 2003-04-14 IS IS6784A patent/IS6784A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL360937A1 (en) | 2004-09-20 |
| AU2001294002A1 (en) | 2002-04-29 |
| BR0107333A (pt) | 2002-08-27 |
| NZ525371A (en) | 2004-11-26 |
| IL150104A0 (en) | 2002-12-01 |
| HUP0301087A2 (hu) | 2003-11-28 |
| MXPA03003417A (es) | 2003-08-07 |
| JP2004511521A (ja) | 2004-04-15 |
| NO20022894D0 (no) | 2002-06-17 |
| ZA200204771B (en) | 2003-09-15 |
| WO2002032428A1 (en) | 2002-04-25 |
| KR20020062970A (ko) | 2002-07-31 |
| SE0003766D0 (sv) | 2000-10-18 |
| US20050101611A1 (en) | 2005-05-12 |
| SK4732003A3 (en) | 2003-10-07 |
| EP1351692A1 (en) | 2003-10-15 |
| CA2425831A1 (en) | 2002-04-25 |
| NO20022894L (no) | 2002-08-15 |
| HUP0301087A3 (en) | 2005-06-28 |
| CN1400902A (zh) | 2003-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20022894L (no) | Oral formulering omfattende en inhibitorforbindelse av ileum- galle transport og en HMG CO-A reduktase inhibitor | |
| IL175615A0 (en) | Pharmaceutical compositions and kits containing a cholinesterase inhibitor and an antidepressant | |
| IL168224A (en) | Sirna compositions for inhibition of hif-1 alpha | |
| GB9920872D0 (en) | Benzophenones as inhibitors of reverse transcriptase | |
| AU9092501A (en) | Compositions and methods for inhibition of hiv-1 infection | |
| DK1341531T3 (da) | Lactamforbindelser til inhibering af beta-amyloidpeptidfrigivelse eller - syntese | |
| PL365983A1 (en) | Surfactant composition for gypsum plaster boards | |
| NO20025586D0 (no) | Inhibitorer for 11-beta-hydroxy steroid dehydrogenase type 1 | |
| HUP0300371A3 (en) | Tag library compounds, compositions, kits and methods of use | |
| IS5865A (is) | Lyfjasamsetningar með stýrða losun sem innihalda CGMP PDE-5 lata | |
| PL364658A1 (en) | Benzophenones as inhibitors of reverse transcriptase | |
| HUP0302555A3 (en) | Pharmaceutical compositions containing gaba agonists and aldose reductase inhibitors | |
| GB2353793B (en) | Method of use of corrosion inhibitor compositions | |
| AU2002358067A1 (en) | Nitrogen-containing compounds as corrosion inhibitors | |
| PL359556A1 (en) | Method - use of cox-2 inhibitors for preventing immunodeficiency | |
| PL369312A1 (en) | Novel compounds and compositions as cathepsin inhibitors | |
| EE200300201A (et) | Püranoonsete proteaasi inhibiitorite iseemulgeeruva kompositsiooni oraalne doos | |
| IL159125A0 (en) | Novel compounds and compositions as cathepsin inhibitors | |
| IL168382A (en) | Functional fluid compositions containing erosion inhibitors | |
| EP0912652A4 (en) | CORROSION INHIBITORS FOR CEMENT COMPOSITIONS | |
| AU2002224550A1 (en) | Corrosion inhibitors | |
| EP1541139A4 (en) | DRUG COMPOSITION WITH NF-KAPPA B HEMMER | |
| SE0302361L (sv) | Inhibering av upptagning av monoamin | |
| MXPA03001247A (es) | Composiciones que contienen inhibidor de dihidrofolato reductasa y folato. | |
| GB2370367B (en) | Chemical amplifying type positive resist composition |